SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Andromeda Biotech Successfully Completes Patient Recruitment in Phase III Confirmatory Trial for Its Lead Drug, "DiaPep277" for Type 1 Diabetes